» Articles » PMID: 16243977

The Influence of Mitochondrial KATP-channels in the Cardioprotection of Preconditioning and Postconditioning by Sevoflurane in the Rat in Vivo

Overview
Journal Anesth Analg
Specialty Anesthesiology
Date 2005 Oct 26
PMID 16243977
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Volatile anesthetics induce myocardial preconditioning and can also protect the heart when given at the onset of reperfusion-a practice recently termed "postconditioning." We investigated the role of mitochondrial KATP (mKATP)-channels in sevoflurane-induced cardioprotection for both preconditioning and postconditioning alone and whether there is a synergistic effect of both. Rats were subjected to 25 min of coronary artery occlusion followed by 120 min of reperfusion. Infarct size was determined by triphenyltetrazolium staining. The following protocols were used: 1) preconditioning (S-Pre, n = 10, achieved by 2 periods of 5 min sevoflurane administration (1 MAC) followed by 10 min of washout); 2) sevoflurane postconditioning (1 MAC of sevoflurane given for 2 min at the beginning of reperfusion; S-Post, n = 10); 3) administration before and after ischemia (S-Pre + S-Post, n = 10). Protocols 1-3 were repeated in the presence of 5-hydroxydecanoate (5HD), a specific mKATP-channel-blocker (S-Pre + S-Post + 5HD, S-Pre + 5HD: n = 10; S-Post + 5HD: n = 9). Nine rats served as untreated controls (CON) or received 5HD alone (5HD, n = 10). Both S-Pre (23% +/- 13% of the area at risk, mean +/- sd) and S-Post (18% +/- 5%) reduced infarct size compared with CON (49% +/- 11%, both P < 0.05). S-Pre + S-Post resulted in a larger reduction of infarct size (12% +/- 5%, P = 0.054 versus S-Pre) compared with administration before or after ischemia alone. 5HD diminished the protection in all three sevoflurane treated groups (S-Pre + 5HD, 35% +/- 12%; S-Post + 5HD, 44% +/- 12%; S-Pre + S-Post + 5HD, 46% +/- 14%;) but given alone had no effect on infarct size (41% +/- 13%). Sevoflurane preconditioning and postconditioning protects against myocardial ischemia-reperfusion injury. The combination of preconditioning and postconditioning provides additive cardioprotection and is mediated, at least in part, by mKATP-channels.

Citing Articles

Cardioprotective Efficacy of Sevoflurane in Patients With Rheumatic Heart Disease Undergoing Heart Valve Surgery Under Cardiopulmonary Bypass.

Lam V, Kinh N, Ly N J Saudi Heart Assoc. 2024; 36(2):120-127.

PMID: 39469525 PMC: 11518043. DOI: 10.37616/2212-5043.1384.


miR-652-3p Suppressed the Protective Effects of Isoflurane Against Myocardial Injury in Hypoxia/Reoxygenation by Targeting ISL1.

Qi K, Cao F, Wang J, Wang Y, Li G Cardiovasc Toxicol. 2024; 24(7):646-655.

PMID: 38801481 DOI: 10.1007/s12012-024-09870-5.


Ischemic Tolerance-A Way to Reduce the Extent of Ischemia-Reperfusion Damage.

Burda R, Burda J, Morochovic R Cells. 2023; 12(6).

PMID: 36980225 PMC: 10047660. DOI: 10.3390/cells12060884.


The Protective Effect of Sevoflurane Conditionings Against Myocardial Ischemia/Reperfusion Injury: A Systematic Review and Meta-Analysis of Preclinical Trials in Models.

Hu B, Tian T, Hao P, Liu W, Chen Y, Jiang T Front Cardiovasc Med. 2022; 9:841654.

PMID: 35571167 PMC: 9095933. DOI: 10.3389/fcvm.2022.841654.


HNO Protects the Myocardium against Reperfusion Injury, Inhibiting the mPTP Opening via PKCε Activation.

Mancardi D, Pagliaro P, Ridnour L, Tocchetti C, Miranda K, Juhaszova M Antioxidants (Basel). 2022; 11(2).

PMID: 35204265 PMC: 8869498. DOI: 10.3390/antiox11020382.